Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Baptiste Mear

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|March 8, 2021
[Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Tamim Alsuliman, Laurianne Drieu La Rochelle, Arnaud Campidelli, et al.
American Journal of Respiratory and Critical Care Medicine|February 22, 2014
Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasomeEmmanuel Faure, Jean-Baptiste Mear, Karine Faure, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Leukemia|August 12, 2022
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) studyChristophe Desprez, Jérémie Riou, Pierre Peterlin, et al.
Transfusion|November 19, 2016
Blood transfusion in hematologic intensive care unitSylvain P Chantepie, Jean-Baptiste Mear, Jean-Jacques Parienti, et al.
Leukemia & Lymphoma|June 1, 2017
Increased frequencies of circulating and tumor-resident Vδ1<sup>+</sup> T cells in patients with diffuse large B-cell lymphomaEmilie Reboursiere, Anne-Claire Gac, Anthony Garnier, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2019
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantationGuillaume Manson, Jean-Baptiste Mear, Charles Herbaux, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Bone Marrow Transplantation|October 19, 2022
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TCPaul Chauvet, Annalisa Paviglianiti, Myriam Labopin, et al.
Bone Marrow Transplantation|December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMTTomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|March 8, 2021
[Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Tamim Alsuliman, Laurianne Drieu La Rochelle, Arnaud Campidelli, et al.
American Journal of Respiratory and Critical Care Medicine|February 22, 2014
Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasomeEmmanuel Faure, Jean-Baptiste Mear, Karine Faure, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 21, 2026
Infectious events in fit patients with relapsed or refractory acute myeloid leukemia treated with azacitidine-venetoclax or intensive chemotherapyMaxime Bobo, Lucas Lefevre, Paul Mallet-Guy, et al.
Leukemia|August 12, 2022
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) studyChristophe Desprez, Jérémie Riou, Pierre Peterlin, et al.
Transfusion|November 19, 2016
Blood transfusion in hematologic intensive care unitSylvain P Chantepie, Jean-Baptiste Mear, Jean-Jacques Parienti, et al.
Leukemia & Lymphoma|June 1, 2017
Increased frequencies of circulating and tumor-resident Vδ1<sup>+</sup> T cells in patients with diffuse large B-cell lymphomaEmilie Reboursiere, Anne-Claire Gac, Anthony Garnier, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2019
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantationGuillaume Manson, Jean-Baptiste Mear, Charles Herbaux, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Bone Marrow Transplantation|October 19, 2022
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TCPaul Chauvet, Annalisa Paviglianiti, Myriam Labopin, et al.
Bone Marrow Transplantation|December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMTTomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Pageof 3